Revealing culturable fungal microbiome communities from the Arabian Peninsula desert representing a unique source of biochemicals for drug discovery and biotechnology.

Walaa Mousa, Najwa Alramadan, Rose Ghemrawi, Tareq Abu Izneid
Author Information
  1. Walaa Mousa: College of Pharmacy, Mansoura University, Mansoura, 35516, Egypt. ORCID
  2. Najwa Alramadan: College of Pharmacy, Mansoura University, Mansoura, 35516, Egypt. ORCID
  3. Rose Ghemrawi: College of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
  4. Tareq Abu Izneid: Monash Rural Health, Churchill, School of Rural Health, Faculty of Medicine, nursing and health sciences, Monash University, Victoria, 3844, Australia.

Abstract

Background: Microbes living at extremes evolve unique survival strategies to adapt to challenging environmental conditions. Among these strategies is their distinctive metabolic potential and ability to produce specialized metabolites enabling them to compete for limited resources and defend against predators. These metabolites have significant potential in pharmaceutical and industrial applications, particularly in the development of drugs and biochemicals.
Objectives: This study aimed to investigate the culturable fungal communities associated with four desert plants and their surrounding soils in the Arabian Peninsula desert to identify their bioactive properties.
Methods: A total of 12 distinct fungal species were isolated from the plants and soils. Each plant hosted a unique set of fungi, demonstrating the diversity of desert-adapted fungal communities. Biological activities of the fungal extracts were evaluated through various assays, including antimicrobial, antifungal, anticancer, and antioxidant properties.
Results: harbors the most diverse fungal community, dominated by genera such as , , , , and species comprise 33% of the total isolates, followed by at 16%. All extracts exhibit diverse activities, with species demonstrating the highest antioxidant activities and total phenolic and flavonoid content. Fungi from , particularly sp., sp., and sp., display potent activity against , while sp., sp., and sp. exhibit moderate inhibition against
Conclusion: This study highlights the importance of exploring extremophilic microorganisms, such as those found in desert ecosystems, as they offer a wealth of compounds that could address current challenges in drug discovery and biotechnology.

Keywords

References

  1. Int Microbiol. 2024 Dec;27(6):1677-1691 [PMID: 38506948]
  2. Biotechnol Biofuels. 2020 Apr 01;13:62 [PMID: 32266008]
  3. Appl Biochem Biotechnol. 2022 Sep;194(9):3984-4001 [PMID: 35579741]
  4. Molecules. 2021 Nov 11;26(22): [PMID: 34833917]
  5. 3 Biotech. 2020 Mar;10(3):107 [PMID: 32095421]
  6. Saudi J Biol Sci. 2024 Feb;31(2):103911 [PMID: 38268781]
  7. BMC Complement Med Ther. 2023 Sep 30;23(1):347 [PMID: 37777711]
  8. Microb Cell Fact. 2023 Jan 12;22(1):8 [PMID: 36635695]
  9. Appl Microbiol Biotechnol. 2020 Mar;104(5):1891-1904 [PMID: 31932894]
  10. J Nat Prod. 2003 Dec;66(12):1567-73 [PMID: 14695798]
  11. J Plant Physiol. 2023 Jan;280:153878 [PMID: 36493668]
  12. Front Microbiol. 2021 Jul 13;12:691296 [PMID: 34326825]
  13. Cancers (Basel). 2021 May 31;13(11): [PMID: 34073059]
  14. BMC Complement Med Ther. 2023 Jul 22;23(1):261 [PMID: 37481531]
  15. Front Microbiol. 2022 Jun 23;13:868081 [PMID: 35814642]
  16. Tumour Biol. 2016 Apr;37(4):4479-91 [PMID: 26496737]
  17. J Nat Prod. 2000 Oct;63(10):1447-8 [PMID: 11076576]
  18. Front Microbiol. 2018 Feb 01;9:95 [PMID: 29449831]
  19. Lett Appl Microbiol. 2021 Mar;72(3):263-274 [PMID: 33063859]
  20. Cell. 2019 Apr 4;177(2):361-369.e10 [PMID: 30951668]
  21. Fitoterapia. 2021 Apr;150:104856 [PMID: 33582267]
  22. J Environ Sci Health B. 2011;46(7):623-9 [PMID: 21749250]
  23. Antimicrob Agents Chemother. 2019 Jul 25;63(8): [PMID: 31182532]
  24. Z Naturforsch C J Biosci. 2005 Nov-Dec;60(11-12):844-8 [PMID: 16402543]
  25. BMC Complement Med Ther. 2023 Sep 15;23(1):323 [PMID: 37715184]
  26. Bioorg Chem. 2019 Mar;83:98-104 [PMID: 30343206]
  27. J Microbiol Biotechnol. 2023 Jun 28;33(6):806-822 [PMID: 36908276]
  28. Nutrients. 2021 Jun 15;13(6): [PMID: 34203776]
  29. J Fungi (Basel). 2023 Jan 03;9(1): [PMID: 36675893]
  30. Sci Total Environ. 2021 May 10;768:144666 [PMID: 33736318]
  31. Front Plant Sci. 2024 Mar 05;15:1294173 [PMID: 38510442]
  32. Life Sci. 2004 Mar 12;74(17):2157-84 [PMID: 14969719]
  33. Saudi J Biol Sci. 2022 Apr;29(4):2409-2420 [PMID: 35531195]
  34. J Nat Prod. 2011 Jan 28;74(1):79-81 [PMID: 21174408]
  35. BMC Microbiol. 2017 Mar 7;17(1):44 [PMID: 28264654]
  36. Chem Biodivers. 2020 Oct;17(10):e2000496 [PMID: 32840051]
  37. Front Microbiol. 2018 Dec 19;9:3167 [PMID: 30619225]
  38. J Fungi (Basel). 2016 Apr 30;2(2): [PMID: 29376930]
  39. Evid Based Complement Alternat Med. 2022 Apr 22;2022:9600079 [PMID: 35497914]
  40. Front Fungal Biol. 2022 Jan 04;2:796010 [PMID: 37744113]
  41. J Nat Prod. 2000 Nov;63(11):1529-30 [PMID: 11087599]
  42. Molecules. 2021 Jan 27;26(3): [PMID: 33513835]
  43. PeerJ. 2023 Jun 27;11:e15525 [PMID: 37397024]
  44. Int J Mol Sci. 2023 May 22;24(10): [PMID: 37240446]
  45. BMC Plant Biol. 2022 Feb 5;22(1):64 [PMID: 35123400]
  46. Int J Phytoremediation. 2021;23(14):1444-1456 [PMID: 33765399]
  47. Biotechnol Biofuels. 2016 Jul 20;9:148 [PMID: 27446237]
  48. Environ Monit Assess. 2021 Mar 24;193(4):214 [PMID: 33759035]
  49. Int J Mol Sci. 2023 Apr 07;24(8): [PMID: 37108065]
  50. Front Microbiol. 2023 Nov 02;14:1267404 [PMID: 38029186]
  51. Molecules. 2022 Mar 05;27(5): [PMID: 35268806]
  52. Arch Microbiol. 2023 Aug 11;205(9):304 [PMID: 37566125]
  53. Microbiology (Reading). 2022 Aug;168(8): [PMID: 35943865]
  54. Appl Microbiol Biotechnol. 2023 Feb;107(4):1077-1093 [PMID: 36648526]
  55. Front Plant Sci. 2022 Mar 03;13:816858 [PMID: 35310624]
  56. Fitoterapia. 2011 Jul;82(5):777-81 [PMID: 21497643]
  57. Phytomedicine. 2000 Jan;6(6):474-6 [PMID: 10715852]
  58. Front Microbiol. 2022 Feb 28;13:819770 [PMID: 35295309]
  59. Microorganisms. 2023 Feb 26;11(3): [PMID: 36985164]
  60. Molecules. 2023 Apr 19;28(8): [PMID: 37110814]
  61. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):166-180 [PMID: 30714404]
  62. Mol Cancer Ther. 2005 Oct;4(10):1569-76 [PMID: 16227407]
  63. Biofactors. 2023 May-Jun;49(3):663-683 [PMID: 36744732]
  64. Plant J. 2018 Jan;93(1):34-49 [PMID: 29083116]
  65. Heliyon. 2024 Aug 19;10(16):e36548 [PMID: 39262988]
  66. Appl Environ Microbiol. 2003 Aug;69(8):4788-93 [PMID: 12902272]
  67. Nat Prod Res. 2021 Nov;35(21):4148-4153 [PMID: 32174195]
  68. Biologics. 2024 Aug 06;18:207-228 [PMID: 39130166]
  69. Iran J Pharm Res. 2019 Winter;18(1):422-429 [PMID: 31089377]
  70. BMC Plant Biol. 2024 Feb 28;24(1):150 [PMID: 38418956]
  71. Arch Microbiol. 2022 Jul 1;204(7):443 [PMID: 35776209]
  72. Front Microbiol. 2017 May 03;8:769 [PMID: 28515715]
  73. Fitoterapia. 2017 Nov;123:23-28 [PMID: 28958956]
  74. Environ Sci Pollut Res Int. 2016 May;23(9):8421-30 [PMID: 26782320]
  75. Plants (Basel). 2023 Mar 10;12(6): [PMID: 36986963]
  76. J Exp Clin Cancer Res. 2021 Jun 21;40(1):197 [PMID: 34154610]
  77. Crit Rev Microbiol. 2020 Nov;46(6):727-749 [PMID: 33044884]
  78. Plant Biol (Stuttg). 2012 Sep;14(5):859-63 [PMID: 22672065]
  79. Arch Microbiol. 2023 Jan 10;205(2):61 [PMID: 36625985]
  80. Planta Med. 2018 Feb;84(3):182-190 [PMID: 28847019]
  81. Indian J Microbiol. 2013 Jun;53(2):175-80 [PMID: 24426105]
  82. Environ Res. 2023 Jul 15;229:116008 [PMID: 37121347]
  83. J Fungi (Basel). 2023 Aug 21;9(8): [PMID: 37623634]
  84. Nat Rev Microbiol. 2017 Nov;15(11):661-674 [PMID: 28919635]

MeSH Term

Desert Climate
Fungi
Drug Discovery
Biotechnology
Mycobiome
Antioxidants
Soil Microbiology
Microbiota

Chemicals

Antioxidants

Word Cloud

Created with Highcharts 10.0.0fungalspdesertuniqueculturablecommunitiestotalspeciesactivitiesantioxidantstrategiespotentialmetabolitesparticularlybiochemicalsstudyplantssoilsArabianPeninsulabioactivepropertiesfungidemonstratingextractsantimicrobialdiverseexhibitdrugdiscoverybiotechnologymicrobiomeBackground:MicrobeslivingextremesevolvesurvivaladaptchallengingenvironmentalconditionsAmongdistinctivemetabolicabilityproducespecializedenablingcompetelimitedresourcesdefendpredatorssignificantpharmaceuticalindustrialapplicationsdevelopmentdrugsObjectives:aimedinvestigateassociatedfoursurroundingidentifyMethods:12distinctisolatedplanthostedsetdiversitydesert-adaptedBiologicalevaluatedvariousassaysincludingantifungalanticancerResults:harborscommunitydominatedgeneracomprise33%isolatesfollowed16%highestphenolicflavonoidcontentFungidisplaypotentactivitymoderateinhibitionConclusion:highlightsimportanceexploringextremophilicmicroorganismsfoundecosystemsofferwealthcompoundsaddresscurrentchallengesRevealingrepresentingsourceDesertcytotoxicmolecules

Similar Articles

Cited By

No available data.